Across the global R&D landscape, innovation speed defines competitiveness. Yet, even world-class research teams lose enormous productivity to the same hidden problem: inefficient lab operations.

Pharma and biotech organizations invest billions in R&D every year — yet most still struggle to answer a simple question: Where are our lab assets,